Journal article
NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas
Pancreas, Vol.39(6), pp.735-752
08/2010
DOI: 10.1097/MPA.0b013e3181ebb168
PMCID: PMC3100728
PMID: 20664472
Abstract
Well-differentiated neuroendocrine tumors (NETs) of the stomach and pancreas represent 2 major subtypes of gastrointestinal NETs. Historically, there has been little consensus on the classification and management of patients with these tumor subtypes. We provide an overview of well-differentiated NETs of the stomach and pancreas and describe consensus guidelines for the treatment of patients with these malignancies.
Details
- Title: Subtitle
- NANETS treatment guidelines: well-differentiated neuroendocrine tumors of the stomach and pancreas
- Creators
- Matthew H Kulke - Dana-Farber Cancer InstituteLowell B Anthony - Louisiana State UniversityDavid L Bushnell - University of IowaWouter W de Herder - Erasmus University RotterdamStanley J Goldsmith - Cornell UniversityDavid S Klimstra - Memorial Sloan Kettering Cancer CenterStephen J Marx - National Institutes of HealthJanice L Pasieka - University of CalgaryRodney F Pommier - Oregon Health & Science UniversityJames C Yao - GI Medical OncologyRobert T Jensen - National Institutes of HealthNorth American Neuroendocrine Tumor Society (NANETS)
- Resource Type
- Journal article
- Publication Details
- Pancreas, Vol.39(6), pp.735-752
- DOI
- 10.1097/MPA.0b013e3181ebb168
- PMID
- 20664472
- PMCID
- PMC3100728
- ISSN
- 0885-3177
- eISSN
- 1536-4828
- Grant note
- ZIA DK053200-19 / Intramural NIH HHS K23 CA093401-05 / NCI NIH HHS Z01 DK053215-02 / Intramural NIH HHS K23 CA093401-04 / NCI NIH HHS K23 CA093401-03 / NCI NIH HHS K23 CA093401-02 / NCI NIH HHS K23 CA093401-01A2 / NCI NIH HHS Z99 DK999999 / Intramural NIH HHS Z01 DK053200-17 / Intramural NIH HHS K23 CA093401 / NCI NIH HHS
- Language
- English
- Date published
- 08/2010
- Academic Unit
- Radiology
- Record Identifier
- 9984318812202771
Metrics
19 Record Views